UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026919
Receipt number R000030881
Scientific Title The development of new uterine manipulator for uterine malignancies
Date of disclosure of the study information 2017/06/01
Last modified on 2018/10/15 18:34:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The development of new uterine manipulator for uterine malignancies

Acronym

The development of new uterine manipulator

Scientific Title

The development of new uterine manipulator for uterine malignancies

Scientific Title:Acronym

The development of new uterine manipulator

Region

Japan


Condition

Condition

endometrial cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Examination of safety and efficacy of new uterine manipulater for endometrial cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Peri-operative complication

Key secondary outcomes

post operative survival time and disease free survival time


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

use the new uterine manipulator and examine the safety and efficacy of the new manipulator

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

stage IA endometrial cancer
aged over 20 yo
patient with informed consent

Key exclusion criteria

narrow vagina
severe comorbidity
PS > 2

Target sample size

155


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kobayashi Eiji

Organization

Osaka University

Division name

OB GYN

Zip code


Address

Suita City, yamadaoka 2-2

TEL

0668793355

Email

ekobayashi@gyne.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kobayashi Eiji

Organization

Osaka University

Division name

OBGYN

Zip code


Address

Suita City, yamadaoka 2-2

TEL

0668793355

Homepage URL


Email

ekobayashi@gyne.med.osaka-u.ac.jp


Sponsor or person

Institute

OBGYN

Institute

Department

Personal name



Funding Source

Organization

Osaka university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部付属病院


Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 23 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 04 Month 10 Day

Last modified on

2018 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030881


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name